BRIEF published on 03/17/2025 at 08:35, 1 year 3 months ago Emmanuel Olivier Intègre le Conseil d'Administration de MACOMPTA.FR Conseil D'administration Stratégie Financière Technologies Macompta.fr Emmanuel Olivier
BRIEF published on 03/17/2025 at 08:35, 1 year 3 months ago Emmanuel Olivier Joins the Board of Directors of MACOMPTA.FR Board Of Directors Technologies Financial Strategy Macompta.fr Emmanuel Olivier
PRESS RELEASE published on 03/17/2025 at 08:30, 1 year 3 months ago MACOMPTA.FR : M. Emmanuel Olivier rejoint le Conseil d'administration Nomination de M. Emmanuel Olivier au Conseil d'administration de MACOMPTA.FR, éditeur de solutions logicielles pour les petites entreprises Conseil D'administration Solutions Logicielles Macompta.fr Emmanuel Olivier Gestion Entreprise
PRESS RELEASE published on 03/17/2025 at 08:30, 1 year 3 months ago MACOMPTA.FR : Emmanuel Olivier joins the Board of Directors Emmanuel Olivier appointed as Director of MACOMPTA.FR, bringing over 25 years of tech sector experience. His strategic vision will support company's development Board Of Directors Technology Sector Strategic Vision Macompta.fr Emmanuel Olivier
BRIEF published on 02/28/2025 at 17:50, 1 year 3 months ago MACOMPTA.FR : Croissance du Chiffre d'Affaires au 1er Semestre 24/25 Chiffre D'affaires Croissance Financière Résultats Semestriels Solutions Logicielles Macompta.fr
BRIEF published on 02/28/2025 at 17:50, 1 year 3 months ago MACOMPTA.FR: Growth in Turnover in the First Half of 24/25 Software Solutions Half-year Results Turnover Financial Growth Macompta.fr
PRESS RELEASE published on 02/28/2025 at 17:45, 1 year 3 months ago MACOMPTA.FR - Résultats du 1er semestre 24/25, CHIFFRE D'AFFAIRES EN FORTE PROGRESSION : + 28,5 % MACOMPTA.FR publie ses résultats du 1er semestre 24/25 : chiffre d'affaires en forte progression de 28,5%. Solide performance financière confirmant la dynamique positive Chiffre D'affaires Performance Résultats Macompta.fr 1er Semestre
PRESS RELEASE published on 02/28/2025 at 17:45, 1 year 3 months ago MACOMPTA.FR - IFRS First-Half Results 24/25, STRONG SALES GROWTH: +28.5% MACOMPTA.FR reports strong sales growth of 28.5% in the first half of the 2024/2025 financial year. The software provider for small business management continues its positive momentum Financial Performance Small Businesses Sales Growth Management Software Macompta.fr
BRIEF published on 02/14/2025 at 18:05, 1 year 4 months ago MACOMPTA.FR : Un acteur clé de la croissance en France Croissance Macompta.fr Logiciels De Gestion Classement 2020-2023
BRIEF published on 02/14/2025 at 18:05, 1 year 4 months ago MACOMPTA.FR: A key player in growth in France Growth Management Software Macompta.fr Ranking 2020-2023
Published on 06/26/2026 at 13:00, 46 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 01:40, 12 hours 6 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 14 hours 16 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 15 hours 16 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/26/2026 at 13:32, 13 minutes ago Porsche ranks number one in J.D. Power 2026 U.S. Initial Quality Study
Published on 06/26/2026 at 13:30, 15 minutes ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Published on 06/26/2026 at 13:30, 15 minutes ago AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026
Published on 06/26/2026 at 13:00, 46 minutes ago Schweizer Electronic and Ascent Circuits Plan Strategic Indo-German PCB Cooperation
Published on 06/26/2026 at 07:00, 6 hours 46 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 6 hours 46 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 19 hours 1 minute ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 19 hours 16 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
